OLAPARIB 50 mg Logo (Lynparza 50 mg)
Generic Name: olaparib
Pill with imprint OLAPARIB 50 mg Logo is White, Capsule-shape and has been identified as Lynparza 50 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Lynparza is used in the treatment of ovarian cancer; prostate cancer; pancreatic cancer; breast cancer, metastatic; breast cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OLAPARIB 50 mg Logo
Lynparza
- Generic Name
- olaparib
- Imprint
- OLAPARIB 50 mg Logo
- Strength
- 50 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC)
- 00310-0657 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
titanium dioxide,
shellac,
ferrosoferric oxide,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia
Note: Inactive ingredients may vary.
More about Lynparza (olaparib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (11)
- Drug images
- Pricing & coupons
- En español
- Drug class: PARP inhibitors
- FDA approval history
Patient resources
- Drug Information
- Lynparza (Advanced Reading)
- Lynparza (Olaparib Capsules)
- Lynparza (Olaparib Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.